ANCA Vasculitis — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Re-induction with Rituximab and glucocorticoids
For relapsing GPA/MPA, BSR 2025 guidelines recommend re-induction therapy. Rituximab is preferred over Cyclophosphamide for relapsing disease, based on the RAVE trial showing superiority of Rituximab in relapsing patients. Glucocorticoids are given alongside Rituximab for induction. Simply increasing the maintenance agent dose is insufficient for active relapse with organ involvement. After achieving remission, Rituximab maintenance should be considered.
Reference: BSR 2025 - Management recommendations for ANCA-associated vasculitis